Home / Letter From The Editor (page 120)

Letter From The Editor

Letter from the Editor: ADA Round-Up

The ADA is over and the Endo Society has finished their annual meeting and now we have to get back to the real world of managing patients, battling insurance companies and hoping that we finally get our payments from Medicare. There was a lot of great science at both conferences …

Read More »

Letter from the Editor: News from the ADA

Steve, Andrew and I are in Orlando at the ADA 70th Scientific Sessions and although things are just getting started there is already news in the diabetes sector. Lilly has agreed to co-brand their Humulin insulin line with Walmart, the world’s largest retailer. Beginning in mid-September, Lilly’s Humulin brand of …

Read More »

A Potentially Bad Summer for Patients

This could be a bad summer for patients if things stay as they are. First off it appears that unless the Senate moves within the next day that Carriers for the Centers for Medicare and Medicaid Services (CMS) will begin processing two weeks’ worth of suspended Medicare claims at rates …

Read More »

When is good enough, good enough?

When is good enough, good enough? This past month I have been working on a CE/CME for pharmacists and physicians. The focus has been on diabetes control in the long term care and assisted living facilities. I started on this path because of a conversation with a former colleague who …

Read More »

Letter from the Editor #523

Sometimes you like to take credit for things that you had no effect on but happened anyway. That’s the case with a bill now in front of the United States House of Representatives. Three weeks ago our intern, Issak Smith, broke the story: Medicare Part D: A Boon for Industry …

Read More »